Black Rock Inc. Macrogenics Inc Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MGNX
# of Institutions
133Shares Held
54MCall Options Held
45.1KPut Options Held
143K-
Bellevue Group Ag Kuesnacht, V89.93MShares$13.5 Million0.29% of portfolio
-
Armistice Capital, LLC New York, NY6.3MShares$8.56 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.43MShares$6.02 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$4.42 Million0.02% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.18MShares$4.32 Million0.25% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $83.6M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...